Some drugmakers are trying to game out what’s next and are reaching out to their lobbyists about the impact of Kennedy’s selection.
View original article
Contributor: Rachel Roubein, McKenzie Beard
Some drugmakers are trying to game out what’s next and are reaching out to their lobbyists about the impact of Kennedy’s selection.
View original article
Contributor: Rachel Roubein, McKenzie Beard